enzymat
breakdown
kinin
affect
durat
biolog
action
plasma
halflif
intraven
inject
bradykinin
bk
rang
second
kariya
et
al
bhoola
et
al
kinin
cleav
vitro
vivo
enzym
belong
famili
zincmetallopeptidas
skidgel
serin
peptidas
proteas
erd
yang
jackman
et
al
astacinlik
metallopeptidas
bond
beynon
cathept
enzym
greenbaum
sherman
discoveri
werl
rocha
e
silva
associ
kallikrein
trypsin
decreas
blood
pressur
releas
kinin
bradykinin
bk
lysbk
kallidin
plasma
peptid
inactiv
term
kininas
coin
denot
inactiv
enzym
frey
etal
frey
etal
etal
rocha
e
silva
bhoola
et
al
see
chapter
volum
subsequ
kininas
ilik
enzym
shown
releas
arg
cterminu
ofbkand
lysbk
et
al
wherea
kininas
ii
liber
phesarg
dipeptid
ofbk
yang
moreov
kininas
ii
ident
angiotensin
iconvert
enzym
ace
yang
et
al
yang
et
al
skidgel
earli
studi
note
sulfllydryl
compound
protect
kinin
enzymat
inactiv
rocha
e
silva
frey
etal
yang
lysbk
convert
bk
plasma
erd
et
al
webster
pierc
bk
also
inactiv
remov
arg
enzym
human
erythrocyt
et
al
rat
lung
aminopeptidas
p
catalyz
reaction
simmon
orawski
vane
note
import
pulmonari
circul
metabol
vasoact
substanc
b
k
well
angiotensin
pioneer
experi
review
elsewher
yang
skidgel
lysbk
nine
bk
eight
peptid
bond
hydrolyz
bhoola
et
al
lysbk
convert
bk
cleavag
lyslarg
bond
et
al
webster
pierc
bk
subsequ
possibl
simultan
inactiv
enzym
eight
remain
bond
et
al
fig
recent
mani
peptidas
cleav
b
k
character
primari
structur
establish
jackman
et
al
skidgel
skidgel
bond
beynon
although
bkha
long
util
conveni
substrat
enzym
assay
vitro
import
sever
mechan
vivo
remain
determin
furthermor
although
term
kininas
conveni
describ
enzym
action
singl
type
substrat
mislead
substrat
eg
angiotensin
may
ami
nopept
dase
p
nep
cleav
kininas
know
kininas
cleav
mani
peptid
frequent
avidli
kinin
skidgel
skidgel
role
peptid
metabol
depend
locat
access
particular
substrat
kinet
hydrolysi
skidgel
vital
question
aris
determin
enzym
affect
action
b
k
vivo
introduct
therapeut
use
enzym
inhibitor
question
aris
gavra
et
al
cushman
ondetti
gavra
ondetti
exampl
much
effect
given
enzym
inhibitor
clinic
attribut
protect
b
k
oppos
substrat
enzymat
breakdown
question
especi
appropri
ace
inhibitor
administ
million
patient
inhibitor
neutral
endopeptidas
nep
neprilysin
also
known
enkephalinas
also
test
clinic
eisner
et
al
attract
idea
employ
second
gener
inhibitor
inhibit
two
enzym
eg
nep
ace
make
issu
even
complex
gonzalezvera
et
al
flynn
et
al
french
et
al
figur
illustr
aminoacid
sequenc
bk
site
action
peptidas
numer
enzym
cleav
bk
ace
neutral
endopeptidas
aminopeptidas
p
carboxypeptidas
n
probabl
import
vivo
although
vari
speci
speci
ace
angiotensin
iconvert
enzym
ace
ndomain
ace
two
zincbind
histidin
residu
cdomain
activ
site
mutat
ly
leav
ndomain
activ
site
function
ace
cdomain
ace
two
zincbind
histidin
residu
ndomain
activ
site
mutat
ly
leav
cdomain
activ
site
function
crossreact
ace
enzym
differ
speci
variou
tissu
quit
similar
like
repres
twodomain
somat
ace
skidgel
also
testicular
enzym
germin
ace
contain
ctermin
half
somat
ace
soubrier
et
al
b
human
materi
activ
truncat
ace
purifi
contain
ntermin
half
ndomain
somat
ace
ace
present
vascular
bed
bound
plasma
membran
endotheli
cell
ectoenzym
cleav
circul
pepfid
bk
also
present
subendotheli
structur
although
lower
concentr
epitheli
neuroepitheli
cell
polyclon
antibodi
either
human
kidney
lung
enzym
could
distinguish
ace
prepar
endotheli
epitheli
neuroepitheli
cell
plasma
skidgel
ace
activ
higher
arteri
venou
endotheli
cell
cultur
johnson
et
al
lung
heavi
vascular
capillari
bed
retina
brain
igic
especi
rich
ace
monoclon
antibodi
also
locat
ace
human
myocardi
vascular
endothelium
falkenhahn
et
al
epitheli
cell
gener
contain
ace
endotheli
cell
human
kidney
exampl
contain
time
ace
per
unit
wet
weight
lung
man
anim
except
rat
kidney
proxim
tubular
brush
border
rich
sourc
ace
hall
et
al
schulz
et
al
ace
activ
also
high
microvillar
structur
brush
border
epitheli
line
exampl
small
intestin
choroid
plexu
placenta
skidgel
et
al
b
skidgel
rat
brain
high
ace
activ
found
subforn
organ
area
postrema
substantia
nigra
locu
ceruleu
human
brain
ace
activ
concentr
caudat
nucleu
skidgel
et
al
possibl
highest
concentr
ace
tissu
found
choroid
plexu
igic
et
al
ventricular
surfac
epitheli
cell
rix
et
al
defendini
et
al
choroid
plexu
may
also
sourc
ace
detect
cerebrospin
fluid
rat
rabbit
brain
ace
local
use
label
inhibitor
sh
captopril
autoradiographi
rogerson
et
al
result
agreement
immunohistochem
studi
correa
et
al
skidgel
et
al
sakaguchi
et
al
chai
et
al
skidgel
rogerson
et
al
ace
also
present
mani
human
anim
tissu
includ
fish
gill
electr
organ
torpedo
marmorata
lipk
olson
housefli
cornel
et
al
human
male
reproduct
tract
et
al
chorion
membran
cultur
chorion
cell
alhencgela
et
al
ace
also
seem
wellconserv
enzym
confirm
molecular
clone
sequenc
show
exampl
deduc
aminoacid
sequenc
human
mous
ace
ident
soubrier
et
al
soubrier
et
al
bernstein
et
al
even
drosophila
ace
sequenc
similar
tatei
et
al
physic
structur
properti
ace
purifi
variou
human
tissu
singlechain
glycoprotein
estim
molecular
weight
rang
kda
sdspage
skidgel
appar
discrep
valu
probabl
aris
part
heterogen
carbohydr
content
experiment
variabl
electrophoret
condit
ace
heavili
glycosyl
human
renal
enzym
contain
approxim
carbohydr
differ
howev
carbohydr
moieti
exampl
human
renal
ace
trace
sialic
acid
human
lung
enzym
contain
sialic
acid
residu
per
molecul
agreement
hypothesi
lung
sourc
circul
ace
owe
high
sialic
acid
content
ace
protect
uptak
fiver
lectin
distribut
potenti
glycosyl
site
uneven
ndomain
contain
ten
cdomain
seven
soubrier
et
al
consist
find
extens
glycosyl
weight
natur
occur
activ
ndomain
human
ileal
fluid
molecular
weight
ace
deduc
cdna
sequenc
without
carbohydr
kda
skidgel
similar
mani
pepfidas
ace
zinc
metalloenzym
thu
chelat
agent
sulthydryl
compound
inhibit
ace
complex
activ
site
zn
yang
ace
ph
optimum
neutral
activ
drop
steepli
acid
ph
primarili
due
dissoci
zn
histidin
activ
center
ehler
riordan
initi
idea
b
k
angiotensin
hydrolyz
enzym
protein
yang
et
al
yang
et
al
controversi
angiotensin
convers
almost
entir
chlorid
depend
cleavag
bk
occur
absenc
ciat
approxim
maxim
rate
igic
et
al
studi
rabbit
lung
ace
show
anion
activ
depend
structur
substrat
ph
medium
ehler
riordan
accordingli
substrat
divid
three
class
bk
class
ii
substrat
lower
activ
constant
cithan
angiotensin
class
substrat
wear
describ
two
anion
bind
site
ace
one
primari
activ
site
concentr
clion
vivo
appear
high
enough
ace
fulli
activ
tissu
although
site
clconcentr
may
fluctuat
enough
regul
ace
activ
substrat
possibl
ciion
sensit
membranebound
enzym
vivo
differ
solubil
purifi
enzym
vitro
especi
angiotensin
substrat
igic
et
al
recent
studi
membranebound
recombin
ace
show
cldepend
nand
cdomain
determin
solubl
enzym
jaspard
alhencgela
ace
potenti
mani
function
tissu
vascular
endothelium
although
well
understood
role
cleav
circul
local
releas
kinin
exampl
renal
proxim
tubular
brush
border
ace
may
inactiv
kinin
enter
nephron
glomerular
filtrat
would
otherwis
interfer
renal
autoregul
scicli
et
al
skidgel
et
al
carretero
scicli
although
enzym
bound
tightli
plasma
membran
ace
also
exist
solubl
form
addit
blood
solubl
ace
found
urin
lung
edema
fluid
amniot
fluid
semin
plasma
cerebrospin
fluid
homogen
prostat
epididymi
skidgel
level
age
human
plasma
low
around
among
laboratori
anim
guineapig
plasma
highest
activ
ace
yang
et
al
human
plasma
ace
activ
vari
significantli
person
person
soubrier
et
al
ace
membran
bound
major
protein
project
extracellular
space
ace
contain
potenti
aminoacid
membranespan
region
near
cterminu
mutant
ace
lack
transmembran
domain
secret
primarili
medium
contrast
cell
transfect
fulllength
cdna
synthes
mainli
membranebound
ace
wei
et
al
b
sinc
tightli
bound
membran
ace
must
solubil
prior
purif
either
deterg
erdr
yang
cleav
enzymaticauy
cell
membran
nishimura
et
al
also
shown
trypsinliber
ace
lower
molecular
weight
ace
mobil
membran
deterg
provid
evid
remov
small
anchor
peptid
trypsin
proteolyt
releas
germin
ace
express
cell
may
involv
activ
protein
kinas
c
ehler
et
al
cleavag
site
peptid
chain
mobil
enzym
establish
beldent
et
al
ramchandran
et
al
socal
asecretas
may
one
enzym
solubil
ace
oppong
hooper
lung
tissu
metalloproteas
respons
solubil
membranebound
ace
oppong
hooper
mechan
underli
releas
ace
membran
vivo
subsequ
appear
bodi
fluid
unclear
proteob
cleavag
membran
anchor
peptid
cdomain
like
sinc
discoveri
separ
activ
singl
ndomain
ace
issu
deserv
scrutini
molecular
clone
sequenc
cdna
human
soubrier
et
al
mous
bernstein
et
al
enzym
reveal
ace
two
domain
znzbind
site
activ
center
soubrier
et
al
twodomain
ace
name
somat
ace
enzym
extract
rabbit
testicl
contain
cdomain
activ
site
call
germin
ace
ehler
et
al
kumar
et
al
lattion
et
al
activ
site
contain
two
histidin
glutam
acid
coordin
zinc
atom
soubrier
et
al
well
catalyt
glutam
acid
presum
base
donor
overal
sequenc
ident
two
domain
around
activ
center
soubrier
et
al
although
domain
catalyt
activ
wei
et
al
inhibitor
react
differ
activ
site
nand
cdomain
perich
et
al
perich
et
al
exampl
captopril
lower
ndomain
activ
site
optim
ciconcentr
inhibitor
lower
cdomain
activ
site
wei
et
al
germin
ace
contain
cdomain
ctermin
half
endotheli
ace
uniqu
amino
acid
nterminu
soubrier
et
al
soubrier
et
al
ehler
et
al
true
yet
unexplain
high
concentr
proteas
peptidas
genit
tract
function
testicular
ace
unknown
germin
ace
probabl
ancient
form
enzym
genedupl
event
like
occur
estim
million
year
ago
give
rise
twodomain
form
soubrier
et
al
b
inde
drosophila
ace
singledomain
enzym
like
testicular
ace
strucmrauy
repres
solubl
form
enzym
cornel
et
al
gene
structur
ace
deduc
polymorph
discov
gene
sequenc
due
either
presenc
absenc
bp
fragment
intron
import
insertiondelet
polymorph
aceiidd
bk
metabol
known
aceii
homozygot
ace
activ
lower
tlymphocyt
plasma
acedd
subject
costerouss
et
al
soubrier
et
al
b
cambien
soubrier
chang
level
ace
studi
varieti
condit
kinet
bkhydrolysi
show
much
lower
k
higher
specif
constant
angiotensin
jaspard
et
al
skidgel
follow
chang
plasma
ace
level
like
affect
kinin
inactiv
angiotensin
convers
normal
condit
plasma
ace
like
origin
vascular
endotheli
cell
skidgel
sarcoidosi
lymph
node
contain
high
concentr
ace
releas
rais
enzym
level
circul
lieberman
lieberman
bunt
et
al
silverstein
et
al
silverstein
et
al
granulomat
diseas
gaucher
diseas
leprosi
also
elev
circul
ace
dhopl
et
al
lieberman
ace
low
monocyt
macrophag
induc
glucocorticosteroid
although
level
decreas
plasma
ofsarcoidosi
patient
treat
hormon
glucocorticosteroid
also
elev
ace
concentr
endotheli
cell
mendelsohn
et
al
thyroid
hormon
markedli
affect
plasma
ace
level
reiner
et
al
increas
hyperthyroid
reduc
hypothyroid
etal
brent
etal
addison
diseas
silicosi
asbestosi
berylosi
ace
level
elev
falezza
et
al
bunt
et
al
paradox
chronic
administr
ace
inhibitor
lead
higher
ace
level
plasma
fyhrquist
et
al
brain
local
cell
membran
ace
concentr
lower
huntington
chorea
butterworth
arregui
et
al
lung
circul
ace
presum
releas
vascular
endotheli
cell
injuri
lung
affect
ace
level
plasma
acut
lung
injuri
earli
increas
blood
ace
heck
niederl
enzym
also
appear
pleural
effus
lavag
fluid
perfus
lung
igic
etal
igic
etal
dragov
et
al
malign
lung
tumor
leukemia
ace
activ
plasma
lower
normal
heck
niederl
schweisfurth
etal
b
blood
level
ace
also
tend
lower
hodgldn
diseas
multipl
myeloma
romer
emmertsen
acut
respiratori
distress
syndrom
ard
ace
activ
decreas
serum
bedrossian
et
al
johnson
etal
b
studi
monoclon
antibodi
rais
somat
ace
suggest
ndomain
ofhuman
ace
immunodomin
danilov
et
al
monoclon
antibodi
also
rais
inhibit
ndomain
ace
also
use
bka
substrat
danilov
et
al
antibodi
use
hypox
rat
lung
model
pulmonari
hypertens
local
ace
reduc
capillari
endothelium
hypox
anim
increas
small
muscular
pulmonari
arteri
morrel
etal
hydrolysi
kinin
ace
bradykinin
degre
particip
two
activ
site
ace
bk
hydrolysi
establish
use
mutant
wildtyp
recombin
form
enzym
mutant
one
activ
site
elimin
delet
mutat
two
zincbind
histidin
residu
jaspard
et
al
agreement
previou
find
b
k
cleav
sequenti
remov
ctermin
dipeptid
yield
bki
fig
bki
bk
prefer
substrat
ace
angiotensin
sinc
specif
constant
kcjkm
time
higher
tabl
ndomain
alon
contribut
bk
degrad
activ
cdomain
respons
activ
produc
bki
jaspard
et
al
cdomain
activ
site
depend
activ
hydrolysi
angiotensin
clsensit
cdomain
activ
optim
ciconcentr
similar
condit
bk
activ
fivefold
k
avk
bk
time
higher
cdomain
ndomain
jaspard
et
al
although
ace
frequent
call
peptidyl
dipeptidas
releas
ctermin
tripeptid
desarggbk
fig
latter
product
carboxypeptidas
n
inokuchi
nagamatsu
kca
tripeptid
releas
higher
cleavag
ctermin
dipeptid
bk
k
desarggbk
much
higher
bk
result
much
lower
kcatk
desarggbk
inokuchi
nagamatsu
oshima
et
al
ace
also
liber
protect
ctermin
diand
tripeptid
eg
substanc
p
even
protect
ntermin
tripeptid
gluhistrp
lutein
hormon
releasinghormon
lhrh
skidgel
ntermin
tripeptid
cleav
mainli
ndomain
possibl
meprin
endopeptidas
endopeptidas
also
cleav
desargsbradykinin
site
bradykinin
see
fig
report
potenti
bkinduc
effect
vitro
vivo
inhibitor
ofkininas
appear
initi
due
sole
prolong
halflif
peptid
readili
degrad
et
al
frey
et
al
howev
widespread
clinic
use
ofac
inhibitor
gavra
et
al
gavra
along
develop
angiotensin
ii
receptor
antagonist
timmerman
smith
b
b
kinin
receptor
antagonist
regoli
kyle
burch
bhoola
et
al
linz
et
al
led
renew
interest
role
kinin
mediat
ace
inhibit
editor
note
role
endogen
kinin
therapeut
effect
ace
inhibitor
review
chapter
volum
unlik
ace
inhibitor
exert
major
effect
rais
level
circul
kinin
rather
drug
like
inhibit
breakdown
local
form
kinin
scicli
ace
inhibit
varieti
compound
vitro
reagent
react
zn
cofactor
enzym
eg
edta
sh
compound
snake
venom
peptid
activ
form
clinic
use
inhibitor
eg
enalaprilat
belong
yang
circul
blood
plasma
also
inhibit
ace
inhibit
appear
abolish
dilut
plasma
ace
substrat
also
competit
inhibitor
even
ntermin
tripeptid
argpropro
bk
inhibit
ace
vitro
oshima
studi
sequenc
snake
venom
inhibitor
synthet
ace
inhibitor
design
retain
ctermin
prolin
kato
suzuki
cushman
ondetti
patchett
cord
wyvratt
patchett
two
action
block
angiotensin
ii
releas
prevent
inactiv
bk
effect
ace
inhibitor
may
interpret
differ
way
issu
especi
relev
consid
experiment
therapeut
effect
ace
inhibitor
cardiovascular
diseas
consensu
gavra
parratt
ambrosioni
et
al
coronari
arteri
angiotensin
ii
vasoconstrictor
mitogen
action
caus
cell
prolifer
subendotheli
tissu
contrast
bk
vasodil
antiprolif
least
rat
swartz
et
al
farhi
et
al
sunman
sever
scicli
hartman
margoliu
auchschwelk
et
al
de
meyer
et
al
enalapril
lower
blood
pressur
hypertens
rat
effect
partial
block
administr
bk
receptor
antagonist
carbonel
et
al
captopril
enhanc
skin
microvascular
blood
flow
attribut
prostaglandin
releas
b
k
warren
loi
thu
ace
inhibitor
may
improv
coronari
circul
two
mechan
b
k
receptor
present
heart
muscl
high
affin
b
k
receptor
discov
rat
cardiomyocyt
coupl
ip
product
gprotein
minshal
et
al
hypertens
rat
enalapril
lower
blood
pressur
effect
block
partial
bk
receptor
antagonist
carbonel
et
al
spontan
hypertens
rat
high
dose
ace
inhibitor
prevent
develop
hypertens
left
ventricular
hypertrophi
effect
abolish
b
receptor
antagonist
hoe
gohlk
et
al
b
ace
inhibitor
diminish
neointima
format
induc
balloon
injuri
rat
carotid
arteri
endogen
kinin
contribut
effect
ag
scicli
person
commun
antihypertroph
effect
ace
inhibitor
may
independ
decreas
blood
pressur
kinin
receptor
antagonist
revers
effect
ofac
inhibitor
scicli
ace
inhibitor
inde
may
prevent
wail
thicken
rat
heart
restenosi
neointim
format
speci
shaw
et
al
ace
inhibitor
reduc
myocardi
infarct
size
myocardi
ischemia
reperfus
injuri
liu
et
al
angiotensin
ii
receptor
antagonist
effect
suggest
kinin
respons
ace
inhibitor
also
amelior
cardiac
arrhythmia
induc
attribut
kinin
mediat
komer
cooper
role
bk
potenti
clinic
benefit
side
effect
acut
chronic
administr
ace
inhibitor
still
explor
ace
inhibitor
given
soon
myocardi
infarct
reduc
mortal
develop
sever
heart
failur
gavra
gavra
hall
et
al
pfeffer
whether
cough
promin
side
effect
ace
inhibitor
israili
hall
sempl
caus
prolong
haftlif
b
k
potenti
bk
effect
unclear
bk
may
also
involv
rare
seriou
side
effect
ace
inhibitor
angioneurot
edema
slater
et
al
thepotenti
effect
bk
ace
inhibitor
go
beyond
protect
bk
degrad
decad
research
yield
sever
compound
amplifi
effect
bk
least
guineapig
isol
ileum
vogel
et
al
agent
unrel
structur
rang
snake
venom
peptid
sulihydryl
compound
known
inhibitor
ace
proteas
fibrinopeptid
inhibit
ace
gladner
et
al
ederi
ederi
issu
recent
gain
particular
import
ace
inhibitor
demonstr
improv
function
fail
heart
via
mechan
attribut
potenti
action
b
k
inhibit
metabol
scicli
linz
et
al
detail
discuss
beyond
scope
review
brief
summari
digoxin
reperfus
part
via
endogen
bk
find
follow
linz
et
al
hand
prevent
cardiac
myocyt
necrosi
coronari
vascular
damag
induc
angiotensin
ii
rat
block
lisinopril
well
angiotensin
ii
receptor
antagonist
kabour
et
al
one
studi
administr
synthas
inhibitor
result
develop
hypertens
cardiac
renal
insuffici
prevent
ramiprilat
benefici
effect
attribut
increas
bk
prostaglandin
product
hropot
et
al
ace
inhibitor
enhanc
effect
b
k
energi
metabol
may
improv
cardiac
metabol
dietz
show
bk
potenti
glucos
uptak
part
via
releas
prostaglandin
ace
inhibitor
reduc
lactat
releas
heart
linz
et
al
enhanc
effect
bk
metabol
function
guineapig
heart
improv
ace
inhibitor
decreas
lactic
acid
releas
increas
intracellular
glutathion
effect
attribut
endogen
bk
massoudi
et
al
captopril
increas
glucos
util
patient
ace
inhibitor
caus
hypoglycemia
torlon
boui
benefici
effect
ace
inhibit
reduc
hyperfiltr
experiment
diabet
rat
evid
support
hypothesi
potenti
action
bk
necessarili
due
sole
inhibit
enzymat
breakdown
subject
sever
public
eg
paegelow
et
al
guineapig
ileum
heart
peptid
inactiv
slowli
potenti
ace
inhibitor
almost
instantan
unlik
therefor
due
prolong
halflif
bk
utk
et
al
isol
guineapig
atrium
ace
inhibitor
potenti
effect
b
k
even
aceresist
bk
analog
use
auchschwelk
et
al
minshau
et
al
ace
inhibitor
also
potenti
inotrop
effect
bk
even
ace
inhibit
complet
sequestr
metal
cofactor
minshal
et
al
ace
inhibitor
also
enhanc
releas
endotheliumderiv
hyperpolar
factor
either
b
k
metabol
stabl
bk
analog
ibrahim
et
al
mombouli
vanhoutt
action
attribut
possibl
interact
ace
inhibitor
b
k
receptor
ace
inhibitor
enhanc
relax
isol
coronari
arteri
respons
bk
endotheliumdepend
auchschwelk
et
al
respons
degradationresist
analog
bk
also
potenti
ace
inhibitor
hydrolysi
b
k
observ
vitro
phenomenon
attribut
potenti
effect
bk
rather
inhibit
degrad
remain
establish
howev
whether
ace
inhibitor
affect
bk
receptor
directli
via
interact
ace
may
close
physic
proxim
therebi
enhanc
action
bk
independ
prolong
halflif
neutral
endopeptidas
neprilysin
nep
zincmetallopeptidas
singl
activ
site
contain
canon
hexxh
sequenc
skidgel
howel
et
al
primari
sequenc
well
conserv
among
speci
devault
et
al
six
nonconserv
differ
human
rat
nep
malfroy
et
al
malfroy
et
al
enzym
transmembran
singlechain
protein
amino
acid
contrast
ace
bound
via
uncleav
ntermin
signal
peptid
roy
et
al
nep
distribut
wide
contrast
ace
express
vascular
endotheli
cell
low
johnson
et
al
llorenscort
et
al
howel
et
al
vari
within
vascular
bed
graf
et
al
epitheli
cell
especi
microvillar
structur
rich
nep
johnson
et
al
turner
ronco
et
al
ace
includ
proxim
tubul
kerr
kenni
placenta
johnson
et
al
intestin
choroid
plexu
turner
ronco
et
al
distribut
brain
investig
detail
possibl
neuropeptid
enkephalin
substanc
p
among
substrat
turner
owe
wide
distribut
action
relev
vivo
differ
organ
differ
substrat
ace
relev
high
concentr
nep
male
genit
tract
especi
prostat
gland
et
al
known
nep
name
common
acut
lymphoblast
leukemia
antigen
calla
letart
et
al
lebien
mccormack
present
lymphoblast
absent
matur
lymphocyt
contrast
found
neutrophil
absent
progenitor
cell
connelli
et
al
painter
et
al
nep
cleav
peptid
ntermini
hydrophob
amino
acid
although
molecular
mass
substrat
usual
exceed
kda
nep
second
kininas
ii
releas
ctermin
phesarg
ofbk
although
discov
endopeptidas
cleav
bchain
insulin
kerr
kenni
mani
activ
peptid
substrat
nep
describ
subsequ
includ
enkephalin
schwartz
et
al
endothelin
vijayaraghavan
et
al
atrial
natriuret
peptid
substanc
p
chemotact
peptid
connelli
et
al
skidgel
note
nep
cleav
bk
bond
fig
almenoff
et
al
first
shown
qualit
high
pressur
liquid
chromatographi
although
prolong
incub
also
result
hydrolysi
bond
use
purifi
human
renal
nep
kinet
hydrolysi
establish
tabl
kca
bk
higher
nep
ace
higher
k
izm
vs
im
specif
constant
kcjkm
nep
lower
vs
ii
site
nep
may
import
kininas
includ
epitheli
cell
respiratori
tract
johnson
et
al
dusser
et
al
skelet
muscl
dragov
et
al
neutrophil
connelli
etal
painter
et
al
skidgel
et
al
renal
proxim
tubul
skidgel
et
al
ura
et
al
possibl
human
coronari
vessel
graf
et
al
inhibitor
nep
eg
thiorphan
phosphoramidon
candoxatril
thu
use
tool
explor
function
vivo
peptidas
schwartz
et
al
bralet
et
al
eisner
et
al
nadel
nadel
bertrand
et
al
schilero
et
al
antiprolif
effect
ofbk
farhi
et
al
high
concentr
nep
solid
malign
tumor
may
indic
b
k
substrat
cell
transplant
malign
tumor
rat
fiver
sk
malign
human
liver
cell
dragov
et
al
primari
fiver
rumor
dragov
et
al
contain
much
time
nep
noncancer
tissu
dragov
et
al
nep
level
circul
blood
plasma
normal
low
increas
ard
septic
pneumonia
johnson
et
al
chronic
cholestasi
anoth
condit
enhanc
plasma
nep
activ
swan
et
al
contrast
plasma
level
nep
amniot
fluid
high
spillantini
et
al
ura
colleagu
found
kininas
activ
rat
urin
attribut
high
nep
activ
inject
nep
inhibitor
enhanc
diuret
natriuret
effect
kinin
effect
could
mediat
part
interact
atrial
natriuret
peptid
kinin
rat
kidney
smit
et
al
bralet
et
al
nep
present
high
concentr
develop
edema
perfus
rat
lung
level
perfus
low
dragov
et
al
nep
activ
increas
urin
proxim
tubular
injuri
serum
endstag
renal
diseas
deschodtlanckman
et
al
nortier
et
al
inhibit
nep
rat
bronchial
epithelium
markedli
enhanc
bronchoconstrict
induc
substanc
p
bk
bertrand
et
al
bkinduc
bronchoconstrict
barn
asthmat
patient
enhanc
nep
inhibitor
crimi
et
al
indirect
action
b
k
also
influenc
nep
inhibit
exampl
b
k
releas
substanc
p
nerv
end
cleav
nep
bhoola
et
al
barn
nadel
skidgel
bk
stimul
airway
ciliari
activ
via
prostaglandin
e
releas
rabbit
effect
also
regul
nep
tamaoki
et
al
microvascular
leakag
guineapig
airway
potenti
ace
nep
inhibit
et
al
rat
lung
combin
inhibit
nep
ace
enhanc
effect
subthreshold
dose
b
k
develop
edema
dragov
et
al
inject
bk
left
ventricl
rat
increas
blood
flow
microcircul
airway
yamawaki
et
al
potenti
phosphoramidon
nep
inhibitor
thu
besid
ace
nep
particip
inactiv
bk
rat
heart
sensori
nerv
stimul
enhanc
myocardi
blood
flow
abolish
bk
receptor
blocker
potenti
phosphoramidon
piedimont
et
al
increas
reactiv
combin
administr
inhibitor
two
peptidas
sever
compound
inhibit
nep
ace
ace
aminopeptidas
avail
bralet
et
al
french
et
al
flynn
et
al
gonzalezvera
et
al
exampl
dual
inhibitor
ace
nep
administ
intraven
iv
rat
potenti
hypotens
effect
bk
action
inhibitor
specif
either
enzym
alon
canin
renal
respons
b
k
enhanc
combin
administr
ace
nep
inhibitor
seymour
et
al
seymour
et
al
combin
lower
arteri
blood
pressur
vascular
resist
nonanesthet
dog
seymour
et
al
coadministr
inhibitor
ace
aminopeptidas
p
effect
reduc
blood
pressur
hypertens
rat
inhibit
either
enzym
alon
ag
scicli
et
al
person
commun
carboxypeptidas
catalyz
hydrolysi
ctermin
peptid
bond
peptid
protein
specif
larg
determin
ctermin
andor
penultim
residu
substrat
skidgel
carboxypeptidas
subdivid
two
gener
group
serin
carboxypeptidas
metallocarboxypeptidas
carboxypeptidas
remov
ctermin
arg
bk
term
kininas
fig
exampl
activ
subunit
carboxypeptidas
n
sequenc
ident
carboxypeptidas
enzym
cleav
bk
although
deamidasecathepsin
cleav
ctermin
arg
bk
fig
therefor
may
classifi
kininas
serin
carboxypeptidas
homolog
carboxypeptidas
n
jackman
et
al
skidgel
metallocarboxypeptidas
catalyz
peptid
hydrolysi
mechan
requir
particip
tightli
bound
zinc
atom
essenti
cofactor
skidgel
metallocarboxypeptidas
subdivid
two
categori
base
substrat
specif
carboxypeptidas
atyp
enzym
prefer
hydrophob
ctermin
amino
acid
wherea
carboxypeptidas
btype
enzym
cleav
ctermin
arg
ly
skidgel
sinc
kinin
contain
ctermin
arg
howev
carboxypeptidas
btype
enzym
cleav
essenti
function
zinc
catalysi
carboxypeptidas
inhibit
metal
chelat
agent
skidgel
btype
carboxypeptidas
inhibit
rel
specif
small
synthet
arginin
analog
acid
mgta
guanidinoethylmercaptosuccin
acid
gemsa
plummer
ryan
skidgel
depend
upon
enzym
employ
inhibit
low
micromolar
nanomolar
rang
ph
incub
form
enzym
also
affect
affin
inhibitor
exampl
gemsa
membran
bound
carboxypeptidas
ph
lower
solubil
purifi
enzym
ph
deddish
et
al
replac
zinc
activ
center
dival
cation
notabl
cobalt
cadmium
alter
activ
enzym
exampl
co
increas
carboxypeptidas
activ
tenfold
depend
sourc
enzym
substrat
folk
gladner
marinkov
et
al
skidgel
deddish
et
al
ph
addit
factor
affect
activ
co
deddish
et
al
activ
enzym
low
ph
carboxypeptidas
n
skidgel
et
al
stimul
peptidas
activ
co
due
increas
vma
k
increas
presenc
metal
ion
contrast
cd
inhibit
peptidas
activ
metauocarboxypeptidas
except
carboxypeptidas
u
plasma
carboxypeptidas
b
stimul
skidgel
base
primari
sequenc
mammalian
metallocarboxypeptidas
fall
clearli
two
group
high
sequenc
ident
pancreat
carboxypeptidas
socal
regulatori
carboxypeptidas
pancreat
carboxypeptidas
b
mast
cell
carboxypeptidas
carboxypeptidas
u
skidgel
form
first
group
carboxypeptidas
n
e
second
group
within
group
signific
sequenc
similar
wherea
group
ident
much
lower
data
well
conserv
activ
site
residu
indic
metallocarboxypeptidas
aros
ancestr
gene
duplic
diverg
evolv
two
separ
precursor
gene
one
gave
rise
pancreat
carboxypeptidaselik
enzym
regulatori
carboxypeptidas
n
e
tan
et
al
avi
et
al
discoveri
plasma
carboxypeptidas
inactiv
bk
first
demonstr
endogen
carboxypeptidas
could
regul
activ
peptid
hormon
erd
sloan
although
enzym
given
sever
name
eg
anaphylatoxin
inactiv
creatin
kinas
convers
factor
plasma
carboxypeptidas
b
arginin
carboxypeptidas
lysin
carboxypeptidas
protaminas
origin
design
carboxypeptidas
n
use
size
estim
purifi
nativ
human
carboxypeptidas
n
rang
kda
depend
method
use
kda
frequent
cite
oshima
et
al
plummer
hurwitz
levin
et
al
denatur
condit
dissoci
three
major
band
kda
kda
kda
plummer
hurwitz
levin
et
al
kda
protein
noncatalyt
subunit
wherea
kda
kda
protein
repres
two
form
activ
subunit
levin
et
al
skidgel
carboxypeptidas
n
therefor
tetramer
enzym
compris
two
heterodim
heterodim
contain
one
catalyt
one
noncatalyt
kda
subunit
kda
subunit
heavili
glycosyl
weight
carbohydr
composit
typic
protein
contain
asnlink
complex
carbohydr
chain
plummer
hurwitz
levin
et
al
contrast
activ
subunit
lack
carbohydr
reveal
molecular
clone
kda
subunit
sequenc
similar
metallocarboxypeptidas
rang
gebhard
et
al
clone
sequenc
kda
subunit
howev
reveal
encod
kda
protein
sequenc
similar
kda
activ
subunit
carboxypeptidas
consist
high
carbohydr
content
sequenc
contain
seven
potenti
asnlink
glycosyl
site
serinethreonin
rich
region
may
site
attach
olink
carbohydr
except
featur
domain
compris
half
protein
contain
leucinerich
tandem
repeat
amino
acid
skidgel
tan
pattern
initi
describ
sequenc
leucinerich
although
varieti
mammalian
protein
contain
skidgel
tan
kobe
deisenhof
leucinerich
repeat
region
like
critic
bind
function
protein
kobe
deisenhof
probabl
leucinerich
repeat
region
kda
subunit
mediat
interact
kda
activ
subunit
form
heterodim
nand
ctermin
domain
kda
subunit
link
two
heterodim
form
tetram
skidgel
tan
lack
carbohydr
small
size
rel
instabl
levin
et
al
skidgel
activ
subunit
carboxypeptidas
n
probabl
would
exist
circul
long
vitro
kda
subunit
stabil
activ
subunit
low
ph
levin
et
al
indic
kda
subunit
although
lack
enzymat
activ
import
carri
stabil
activ
subunit
blood
carboxypeptidas
n
cleav
varieti
substrat
contain
ctermin
arg
ly
gener
cleav
ly
faster
arg
although
penultim
residu
also
play
import
role
alanin
prefer
mani
case
skidgel
ph
optimum
carboxypeptidas
n
neutral
rang
retain
minim
activ
ph
erdb
et
al
deddish
et
al
howev
co
still
activ
enzym
ph
surpris
activ
ph
absenc
co
deddish
et
al
enzymat
properti
isol
catalyt
kda
subunit
levin
et
al
agre
intact
kda
tetram
kda
subunit
affect
alloster
interact
enzym
substrat
includ
anaphylatoxin
inhibitor
protamin
skidgel
et
al
tan
et
al
local
carboxypeptidas
n
synthes
fiver
releas
circul
present
rel
high
concentr
approxim
igml
littl
carboxypeptidas
n
activ
found
fiver
oshima
et
al
probabl
enzym
store
secret
soon
synthesi
appar
cell
organ
synthes
enzym
northern
blot
analysi
variou
organ
gave
neg
result
tan
skidgel
unpublish
although
report
carboxypeptidas
n
immunoreact
present
cell
membran
cultur
bovin
pulmonari
arteri
endotheli
cell
ryan
ryan
determin
whether
cell
synthes
enzym
like
take
serum
medium
contrast
cell
membran
cultur
human
pulmonari
arteri
endotheli
cell
high
level
carboxypeptidas
detect
carboxypeptidas
n
naga
et
al
role
carboxypeptidas
n
kininas
carboxypeptidas
n
discov
kininas
cleav
ctermin
arg
bk
fig
although
kca
valu
bki
lower
namrauy
occur
substrat
tabl
bkha
lowest
k
im
ofal
peptid
substrat
test
skidgel
even
though
abil
carboxypeptidas
n
cleav
kinin
vitro
well
document
contribut
degrad
circul
kinin
vivo
probabl
secondari
import
b
k
rapidli
inactiv
ace
singl
passag
pulmonari
circul
vane
also
although
rate
degrad
circul
bk
would
slower
pathway
becom
signific
patient
treat
ace
inhibitor
level
circul
kinin
may
relev
physiolog
action
thought
local
tissu
carretero
scicli
rather
like
repres
spillov
kinin
gener
local
site
nevertheless
kinin
concentr
increas
significantli
blood
undesir
effect
thu
bloodborn
enzym
may
import
prevent
buildup
endogen
peptid
circul
presenc
carboxypeptidas
n
blood
rel
high
concentr
provid
evid
enzym
may
fulfil
function
evid
observ
human
subject
test
found
lack
enzym
complet
even
patient
low
enzym
level
rare
et
al
mathew
et
al
inde
genet
low
blood
level
ofcarboxypeptidas
n
normal
owe
decreas
hepat
synthesi
associ
repeat
attack
angioedema
one
patient
possibl
due
increas
halflif
ofkinin
andor
anaphylatoxin
mathew
et
al
mathew
et
al
condit
affect
hepat
plasma
protein
synthesi
also
alter
plasma
carboxypeptidas
n
level
includ
cirrhosi
liver
caus
decreas
pregnanc
caus
increas
erd
et
al
varieti
diseas
eg
cardiovascular
diseas
diabet
allerg
condit
chang
carboxypeptidas
n
level
et
al
mathew
et
al
although
elev
enzym
level
note
certain
cancer
blood
synovi
fluid
arthrit
patient
et
al
mathew
et
al
schweisfurth
et
al
chercuitt
et
al
relationship
carboxypeptidas
n
level
diseas
state
known
evid
protect
function
carboxypeptidas
n
human
necess
somewhat
indirect
nevertheless
protaminerevers
syndrom
one
condit
low
carboxypeptidas
n
activ
may
involv
protamin
given
routin
neutral
antithrombot
effect
heparin
extracorpor
circul
patient
trigger
catastroph
reaction
consist
pulmonari
vasoconstrict
bronchoconstrict
system
hypotens
lowenstein
et
al
morel
et
al
reaction
attribut
releas
thromboxan
gener
anaphylatoxin
kinin
subsequ
activ
complement
cascad
factor
xii
activ
plasma
kallikrein
colman
morel
et
al
protamin
potent
inhibitor
carboxypeptidas
n
tan
et
al
potenti
decreas
degrad
anaphylatoxin
kinin
may
contribut
syndrom
addit
carboxypeptidas
n
concentr
decreas
normal
initi
cardiopulmonari
bypass
due
primarili
dilut
blood
rabito
et
al
howev
fact
syndrom
rel
rare
incid
approxim
indic
factor
involv
heparin
bind
protamin
revers
inhibit
carboxypeptidas
n
tan
et
al
protamin
given
excess
would
problem
develop
agreement
possibl
administr
heparin
revers
protamin
reaction
two
patient
hypothes
due
reactiv
carboxypeptidas
n
lock
hessel
addit
data
mathew
et
al
indic
carboxypeptidas
n
level
normal
greater
suffici
protect
role
action
bk
mediat
via
bind
activ
b
receptor
bhoola
et
al
howev
cleavag
bk
carboxypeptidas
n
yield
desarggbk
specif
agonist
b
receptor
stimul
varieti
ofproinflammatori
cellular
respons
see
chapter
volum
receptor
system
upregul
respons
injuri
inflamm
may
part
acut
phase
reaction
bhoola
et
al
see
chapter
exampl
mani
isol
tissu
respond
incub
sever
hour
debloi
et
al
bhoola
et
al
noxiou
proinflammatori
stimuli
triton
endotoxin
induc
express
b
receptor
bhoola
et
al
creceliu
et
al
debloi
et
al
inhibit
glucocorticosteroid
debloi
et
al
thu
convers
bk
desarggbk
carboxypeptidas
n
produc
agonist
b
receptor
may
play
import
role
inflammatori
patholog
respons
occur
vivo
support
find
blood
level
desarggbk
higher
nativ
bk
normotens
individu
patient
lowrenin
essenti
hypertens
odya
et
al
discov
signific
carboxypeptidas
blike
activ
membran
fraction
obtain
human
anim
tissu
cell
johnson
et
al
skidgel
et
al
purif
character
uniqu
enzym
name
carboxypeptidas
denot
fact
membranebound
human
carboxypeptidas
yield
singl
band
kda
sodium
dodecyl
sulphatepolyacrylamid
gel
electrophoresi
sdspage
without
reduct
show
singlechain
protein
slightli
higher
valu
kda
obtain
gel
filtrat
presenc
chap
like
caus
bind
enzym
deterg
micel
also
glycoprotein
natur
carboxypeptidas
glycoprotein
joind
tightli
concanavalin
asepharos
mass
reduc
kda
chemic
deglycosyl
data
indic
carbohydr
content
weight
agreement
presenc
six
potenti
asnlink
glycosyl
site
deduc
protein
sequenc
tan
et
al
subcellular
fraction
cell
tissu
carboxypeptidas
firmli
membran
bound
skidgel
et
al
skidgel
howev
primari
sequenc
contain
true
hydrophob
transmembran
span
region
tan
et
al
extrem
cterminu
weakli
hydrophob
region
amino
acid
similar
protein
membran
bound
via
glycosylphosphatidylinositol
gpi
anchor
low
inde
carboxypeptidas
releas
membran
prepar
bacteri
phosphatidylinositolspecif
phospholipas
c
piplc
characterist
featur
gpianchor
protein
deddish
et
al
direct
evid
presenc
gpi
anchor
carboxypeptidas
obtain
label
cultur
madin
darbi
canin
kidney
mdck
cell
high
carboxypeptidas
activ
ethanolamin
antiserum
specif
carboxypeptidas
immunoprecipit
singl
radiolabel
band
solubil
membran
fraction
correspond
size
carboxypeptidas
deddish
et
al
carboxypeptidas
also
found
solubl
form
variou
bodi
fluid
urin
semin
plasma
amniot
fluid
bronchoalveolar
lavag
fluid
skidgel
et
al
skidgel
et
al
b
dragov
et
al
mcgwire
skidgel
mechan
releas
enzym
determin
fact
hydrophob
portion
anchor
remov
indic
either
proteas
phospholipas
involv
deddish
et
al
carboxypeptidas
activ
cobalt
chlorid
inhibit
mgta
gemsa
cadmium
acet
btype
carboxypeptidas
neutral
ph
optimum
cleav
ctermin
arg
ly
varieti
substrat
includ
bk
arginin
lysineextend
opioid
peptid
fig
carboxypeptidas
cleav
ctermin
arg
preferenti
ly
demonstr
faster
cleavag
bzglyarg
bzglyli
although
penultim
residu
promin
affect
rate
hydrolysi
carboxypeptidas
also
hydrolyz
natur
occur
peptid
substrat
kinet
constant
determin
substrat
test
bk
ctermin
phesarg
lowest
k
im
kcatk
ixmlmin
tabl
synthet
substrat
test
ester
substrat
mm
bzglyarginin
acid
cleav
fastest
micromolesminmg
local
carboxypeptidas
found
wide
varieti
tissu
cell
northern
blot
analysi
show
high
level
carboxypeptidas
mrna
human
placenta
lung
kidney
naga
et
al
signific
amount
present
blood
vessel
intestin
brain
peripher
nerv
skidgel
et
al
skidgel
et
al
skidgel
naga
et
al
naga
et
al
lung
immunohistochem
studi
locat
carboxypeptidas
surfac
type
pneumocyt
pulmonari
macrophag
naga
et
al
brain
oligodendrocyt
astrocyt
stain
posit
peripher
nerv
enzym
concentr
outer
aspect
myelin
sheath
schwann
cell
membran
naga
et
al
carboxypeptidas
also
present
solubl
form
variou
bodi
fluid
note
earlier
skidgel
et
al
skidgel
et
al
b
mcgwire
skidgel
recent
discov
monoclon
antibodi
rais
differentiationdepend
cell
surfac
antigen
white
blood
cell
specif
carboxypeptidas
de
saintvi
et
al
rehli
et
al
one
studi
carboxypeptidas
almost
undetect
peripher
blood
monocyt
highli
express
differenti
macrophag
rehli
et
al
similarli
carboxypeptidas
present
preb
lymphocyt
downregul
circul
b
lymphocyt
reexpress
activ
germin
center
b
cell
de
saintvi
et
al
owe
locat
plasma
membran
wide
varieti
cell
tissu
b
k
receptor
also
locat
carboxypeptidas
like
regul
local
action
bk
skidgel
skidgel
carboxypeptidas
n
agonist
b
receptor
produc
carboxypeptidas
fig
howev
locat
plasma
membran
carboxypeptidas
may
perform
role
local
environ
outsid
circul
exampl
site
inflamm
receptor
may
upregul
skidgel
skidgel
bhoola
et
al
epiderm
growth
factor
egf
urogastron
anoth
substrat
carboxypeptidas
relev
kinin
system
egf
aminoacid
kda
peptid
first
isol
mous
submaxillari
gland
carpent
wahl
studi
liver
fibroblast
indic
egf
first
cleav
carboxypeptidas
remov
ctermin
arg
produc
cell
surfac
earli
endosom
schaudi
savag
planck
et
al
renfrew
hubbard
recent
studi
show
purifi
carboxypeptidas
readili
convert
egf
desargssegf
mcgwire
skidgel
incub
egf
mdck
cell
high
carboxypeptidas
activ
result
rapid
convers
h
egf
desargssegf
metabolit
hydrolysi
block
complet
carboxypeptidas
inhibitor
mgta
similar
result
obtain
urin
amniot
fluid
mgta
immunoprecipit
specif
antiserum
carboxypeptidas
abolish
essenti
egf
hydrolysi
mcgwire
skidgel
howev
differ
mitogen
potenc
egf
mdck
cell
convers
egf
desargssegf
requir
mitogen
effect
mcgwire
skidgel
carboxypeptidas
cleav
egf
bk
interest
egf
stimul
growth
breast
stromal
cell
wherea
bk
decreas
growth
caus
concentrationdepend
inhibit
egfsfimul
dna
synthesi
patel
schrey
effect
bk
mediat
b
receptor
impli
first
convert
system
egf
also
potenti
contractil
respons
rabbit
aortic
ring
debloi
et
al
carboxypeptidas
may
involv
inflammatori
patholog
process
virtu
regul
activ
kinin
anaphylatoxin
mediat
mani
inflammatori
effect
import
upor
downregul
carboxypeptidas
differenti
monocyt
macrophag
b
lymphocyt
rehli
et
al
de
saintvi
et
al
known
kidney
carboxypeptidas
may
control
activ
kinin
releas
kallikrein
liber
distal
tubul
scicli
et
al
kinin
stimul
prostaglandin
product
affect
sodium
water
excret
carretero
scicli
mediat
aminoacidinduc
hyperperfus
hyperfiltr
jaffa
et
al
one
studi
hypertens
human
patient
excret
significantli
kininas
normal
individu
major
kininas
kininas
iimura
probabl
carboxypeptidas
thu
increas
releas
carboxypeptidas
urin
could
earli
sign
renal
damag
owe
hypertens
diseas
carboxypeptidas
may
also
import
function
lung
indic
high
level
activ
present
membran
fraction
lung
bovin
guinea
pig
baboon
dog
rat
human
chodimella
et
al
naga
et
al
type
cell
immunohistochemistri
stain
strongli
carboxypeptidas
naga
et
al
compris
total
cell
lung
yet
account
total
surfac
area
cell
cover
layer
surfact
function
primarili
thin
gasperm
membran
air
space
capillari
presenc
carboxypeptidas
surfac
indic
protect
role
enzym
may
also
readili
mobil
cell
surfac
solubl
surfact
layer
bronchoalveolar
lavag
fluid
contain
high
level
carboxypeptidas
dragov
et
al
pulmonari
synthesi
carboxypeptidas
releas
membran
may
upregul
diseas
state
enzym
level
bronchoalveolar
lavag
fluid
elev
almost
fivefold
patient
pneumocyst
bacteri
pneumonia
lung
cancer
carboxypeptidas
also
releas
edema
fluid
rat
lung
experiment
model
lung
injuri
dragov
et
al
b
k
caus
pulmonari
edema
bronchoconstrict
administ
anim
although
carboxypeptidas
inhibitor
mgta
enhanc
either
respons
ichinos
barn
chodimella
et
al
dragov
et
al
caus
potenti
pulmonari
respons
inhibit
nep
ace
chodimella
et
al
dragov
et
al
suggest
involv
three
enzym
metabol
bk
might
relev
persist
dri
cough
one
major
side
effect
encount
administr
ace
kininas
ii
inhibitor
hypertens
patient
israili
hall
sempl
result
increas
concentr
peptid
bkin
respiratori
tract
moric
etal
add
potenti
import
carboxypeptidas
lung
patient
studi
guinea
pig
reveal
carboxypeptidas
mtype
enzym
exist
airway
mgta
enhanc
noncholinerg
bronchoconstrictor
respons
capsaicin
vagu
nerv
stimul
desmaz
et
al
probabl
involv
releas
peptid
nerv
end
although
b
k
presum
involv
desmaz
et
al
respons
mgta
attribut
inhibit
activ
airway
could
also
due
inhibit
carboxypeptidas
vagu
nerv
present
high
concentr
naga
et
al
whether
carboxypeptidas
pulmonari
type
cell
function
unrel
enzymat
activ
unknown
nevertheless
aminopeptidas
n
intestin
epitheli
cell
act
receptor
coronavirus
yeager
et
al
leav
possibl
carboxypeptidas
also
may
receptor
infecti
agent
lung
hypothesi
support
recent
discoveri
hepat
bvirusbind
protein
btype
carboxypeptidas
signific
sequenc
ident
carboxypeptidas
n
e
kuroki
et
al
final
function
carboxypeptidas
mani
locat
remain
explor
exampl
placenta
may
protect
fetu
matern
deriv
peptid
locat
central
nervou
system
cn
myelin
schwann
cell
peripher
nerv
intrigu
may
indic
role
growth
protect
neuron
recent
addit
class
enzym
unstabl
bloodborn
carboxypeptidas
activ
coagul
sever
group
publish
human
serum
higher
argininecarboxypeptidas
activ
plasma
differ
could
explain
chang
carboxypeptidas
n
activ
campbel
okada
hendrik
et
al
sheikh
kaplan
interestingli
erdr
colleagu
note
serum
higher
carboxypeptidas
activ
plasma
reason
differ
investig
retrospect
reason
smaller
differ
recent
studi
result
use
hippurylli
substrat
cleav
slower
enzym
compar
carboxypeptidas
n
addit
cobalt
assay
would
inhibit
carboxypeptidas
u
hendrik
et
al
tan
eaton
investig
show
enzym
uniqu
carboxypeptidas
campbel
okada
hendrik
et
al
hendrik
et
al
unrel
studi
plasminogenbind
protein
fortuit
isol
sequenc
signific
homolog
pancreat
carboxypeptidas
eaton
et
al
although
mani
properti
enzym
quit
similar
carboxypeptidas
u
eaton
cowork
believ
two
enzym
differ
name
one
isol
plasma
carboxypeptidas
b
howev
base
similar
properti
partial
sequenc
inform
investig
believ
ident
shinohara
et
al
wang
et
al
purpos
review
consid
name
carboxypeptidas
u
use
avoid
confus
protein
reveal
ntermin
sequenc
recent
isol
name
thrombinactivat
fibrinolysi
inhibitor
tafi
bajzar
et
al
initi
report
size
partial
purifi
carboxypepfidas
u
kda
hendrik
et
al
complet
purif
plasminogen
affin
column
yield
kda
protein
eaton
et
al
turn
proenzym
activ
trypsin
yield
activ
protein
kda
eaton
et
al
size
enzym
initi
report
hendrik
et
al
may
therefor
repres
carboxypepfidas
u
bound
plasminogen
possibl
protein
multimer
complex
inde
treatment
crude
high
molecular
weight
complex
guanidin
follow
chromatographi
result
isol
activ
enzym
major
protein
band
kda
base
cdna
sequenc
ntermin
sequenc
activ
similar
pancreat
carboxypeptidas
activ
form
molecular
weight
kda
eaton
et
al
work
requir
resolv
discrep
although
procarboxypeptidas
u
glycoprotein
shown
reduct
mass
kda
kda
enzymat
deglycosyl
eaton
et
al
four
potenti
asnlink
glycosyl
site
sequenc
propeptid
segment
eaton
et
al
reason
carboxypeptidas
u
unstabl
serum
partial
purif
fulli
understood
although
like
involv
proteolysi
enzym
activ
coagul
fact
carboxypeptidas
u
high
molecular
weight
complex
min
wherea
guanidin
treatment
chromatographi
isol
activ
enzym
presum
remov
associ
proteas
increas
min
support
hypothesi
addit
purifi
proenzym
activ
trypsin
incub
lead
addit
cleavag
reduc
size
activ
carboxypeptidas
kda
result
inactiv
eaton
et
al
contrast
find
carboxypeptidas
b
similar
reduct
size
inactiv
human
pancreat
enzym
marinkov
et
al
activ
trypsin
carri
presenc
competit
inhibitor
eamino
caproic
acid
secondari
cleavag
block
without
affect
hydrolysi
propeptid
lead
product
stabl
fitli
activ
enzym
carboxypeptidas
u
mark
prefer
either
ctermin
arg
ly
penultim
ala
gli
short
synthet
substrat
hendrik
et
al
hendrik
et
al
eaton
et
al
wang
et
al
tan
eaton
howev
larger
natur
occur
peptid
enzym
cleav
ctermin
arg
faster
ly
low
specif
constant
kcatkm
substrat
carboxypeptidas
u
due
high
k
valu
mm
tan
eaton
higher
carboxypeptidas
n
skidgel
et
al
carboxypeptidas
u
ph
optimum
neutral
rang
contrast
metallocarboxypeptidas
co
inhibit
cd
activ
peptidas
activ
enzym
hendrik
et
al
tan
eaton
local
carboxypeptidas
u
found
blood
exist
inact
proenzym
activ
coagul
presum
serin
proteas
convert
proenzym
clot
campbel
okada
hendrik
et
al
eaton
et
al
although
thrombin
bajzar
et
al
plasminogen
activ
procarboxypeptidas
u
remain
determin
whether
major
activ
pathway
vivo
propeptid
cleav
serin
proteas
level
procarboxypeptidas
u
plasma
high
estim
gml
eaton
et
al
complet
activ
around
plasma
protein
procarboxypeptidas
u
probabl
also
synthes
fiver
consist
clone
cdna
human
fiver
librari
eaton
et
al
role
carboxypeptidas
u
discov
rel
recent
function
carboxypeptidas
u
still
explor
howev
like
play
import
role
fibrinolyr
pathway
regul
lysinemedi
plasminogen
bind
protein
cell
exampl
cleav
ctermin
ly
residu
histidinerich
glycoprotein
fibrin
annexin
ii
enolas
redlitz
et
al
regard
fimction
kininas
interest
one
first
group
identifi
enzym
use
bk
substrat
sheikh
kaplan
note
convers
bk
much
faster
serum
plasma
fivefold
higher
could
account
carboxypeptidas
n
sheikh
kaplan
recent
anoth
group
show
activ
procarboxypeptidas
u
trypsin
plasma
enzym
remov
ctermin
arg
bk
shinohara
et
al
fig
final
kinet
bk
hydrolysi
determin
purifi
enzym
trypsin
activ
synthet
natur
occur
substrat
test
bk
lowest
k
highest
kcatk
howev
report
km
extraordinarili
high
mm
tabl
even
though
lower
substrat
k
mm
exampl
km
bk
peptidas
rang
tabl
rais
question
physiolog
relev
carboxypeptidas
u
degrad
b
k
would
normal
present
concentr
mani
order
magnitud
lower
k
serum
degrad
bk
fivefold
faster
account
carboxypeptidas
n
level
carboxypeptidas
u
may
signific
kininas
certain
circumst
appar
discrep
observ
bk
degrad
serum
calcul
kinet
constant
tabl
understood
moreov
carboxypeptidas
u
would
cleav
bk
blood
complet
inact
proenzym
plasma
may
activ
exampl
injuri
initi
coagul
cascad
involv
serin
carboxypeptidas
degrad
b
k
vivo
explor
detail
two
lysosom
serin
carboxypeptidas
potenti
affect
kinin
activ
patholog
condit
prolylcarboxypeptidas
deamidas
cathepsin
alysosom
protect
protein
activ
site
serin
carboxypepfidas
contain
catalyt
triad
amino
acid
characterist
serin
proteas
order
residu
primari
sequenc
ser
asp
uniqu
prolylendopeptidas
prolyloligopeptidas
famili
serin
proteas
tan
et
al
wherea
deamidas
clearli
belong
serin
carboxypeptidas
famili
regard
sequenc
ident
prolylcarboxypeptidas
sequenc
motif
characterist
serin
carboxypeptidas
prolylendopepfidas
perhap
indic
prolylcarboxypeptidas
link
two
famili
enzym
tan
et
al
prolylcarboxypeptidas
yang
et
yang
et
solubl
singlechain
protein
kda
sodium
dodecyl
sulphatepolyacrylamid
gel
electrophoresi
sdspage
elut
symmetr
peak
kda
gelfi
trafion
chromatographi
indic
dimer
nativ
form
odya
et
al
tan
et
al
glycoprotein
contain
carbohydr
weight
consist
presenc
six
potenti
asnlink
glycosyl
site
matur
protein
sequenc
tan
et
al
cdna
sequenc
indic
protein
contain
signal
peptid
propeptid
tan
et
al
deamidas
purifi
homogen
platelet
substanc
pinactiv
peptidas
jackman
et
al
gel
filtrat
enzym
molecular
mass
kda
wherea
nonreduc
polyacrylamid
gel
electrophoresi
kda
indic
exist
homodim
reduct
sdspage
kda
protein
dissoci
two
chain
kda
kda
chain
label
diisopropylfluorophosph
indic
contain
activ
site
serin
residu
jackman
et
al
first
residu
chain
sequenc
found
ident
sequenc
two
chain
lysosom
protect
protein
name
bind
maintain
activ
stabil
neuraminidas
lysosom
galjart
et
al
defect
protein
caus
sever
genet
diseas
call
galactosialidosi
dazzo
et
al
owe
bind
abil
deamidas
also
isol
lysosom
high
molecular
weight
activ
complex
kda
van
der
horst
et
al
potier
et
al
similar
member
serin
proteas
famili
prolylcarboxypeptidas
deamidas
inhibit
compound
react
activ
site
serin
residu
exampl
sh
diisopropylfluorophosph
coval
label
activ
site
serin
enzym
jackman
et
al
tan
et
al
howev
inhibit
natur
occur
serin
proteas
inhibitor
aprotinin
soybean
trypsin
inhibitor
cxlantitrypsin
cxxantichymotrypsin
etc
odya
et
al
jackman
et
al
tan
et
al
exopeptidas
bind
cleav
intern
peptid
bond
inhibitor
recogn
serin
proteas
deamidas
inhibit
inhibitor
chymotrypsintyp
enzym
cbzglyleuphechcl
chymostatin
due
prefer
cleav
substrat
penultim
hydrophob
residu
jackman
et
al
prolylcarboxypeptidas
deamidas
acid
ph
optima
approxim
hydrolyz
short
synthet
peptid
substrat
jackman
et
al
tan
et
al
interestingli
mani
longer
substrat
enzym
retain
signific
activ
neutral
rang
exampl
ph
prolylcarboxypeptidas
cleav
angiotensin
ii
rate
observ
ph
deamidas
cleav
bk
rate
ph
jackman
et
al
tan
et
al
addit
deamid
ctermin
amid
peptid
substanc
p
deamidas
optim
neutral
ph
jackman
et
al
name
impli
prolylcarboxypeptidas
cleav
peptid
penultim
residu
prolin
odya
et
al
tan
et
al
deamidasecathepsin
deamid
peptid
substanc
p
neurokinin
enkephalinamid
also
cleav
peptid
free
carboxytermini
carboxypeptidas
action
prefer
peptid
contain
hydrophob
residu
pi
andor
posit
exampl
readili
cleav
substanc
p
free
acid
convert
angiotensin
ii
jackman
et
al
cleav
chemotact
peptid
fmetleuph
jackman
et
al
potent
endothelin
degrad
enzym
identifi
jackman
et
al
jackman
et
al
deamidas
prolylcarboxypeptidas
local
lysosom
releas
cell
stimul
eg
platelet
white
blood
cell
appear
extracellular
medium
biolog
fluid
exampl
deamidas
prolylcarboxypeptidas
found
urin
yang
et
al
miller
et
al
prolylcarboxypeptidas
releas
synovi
fluid
addit
lysosom
enzym
sometim
appear
plasma
membran
exocytosi
may
bound
transmembran
membraneassoci
protein
skidgel
et
al
enzym
distribut
ubiquit
mrna
express
highest
human
placenta
lung
liver
prolylcarboxypeptidas
tan
et
al
mous
kidney
placenta
deamidaseprotect
protein
galjart
et
al
deamidas
also
highli
activ
macrophag
well
platelet
endotheli
cell
fibroblast
jackman
et
al
jackman
et
al
jackman
et
al
jackman
et
al
prolylcarboxypeptidas
also
found
white
blood
cell
fibroblast
express
high
level
endotheli
cell
skidgel
et
al
kininas
local
lysosom
serin
carboxypeptidas
would
normal
access
extracellular
kinin
sinc
kinin
system
upregul
inflammatori
condit
lysosom
enzym
releas
leukocyt
cell
enzym
may
gain
access
extracellular
kinin
addit
lysosom
serin
carboxypeptidas
could
modul
kinin
receptor
signal
transduct
cleav
kinin
ligandmedi
receptor
endocytosi
et
al
usual
involv
fusion
endosom
lysosom
result
peptid
degrad
receptor
recycl
yamashiro
maxfield
best
substrat
deamidas
contain
ctermin
hydrophob
residu
eg
endothelin
fmetleuph
furylacryloylpheph
angiotensin
jackman
et
al
jackman
et
al
jackman
et
al
surpris
bk
ctermin
arg
good
substrat
jackman
et
al
fig
clear
howev
presenc
hydrophob
amino
acid
penultim
posit
allow
deamidas
remov
nonhydrophob
amino
acid
carboxypeptidas
action
thu
bk
phearg
angiotensinl
phehi
collect
cleav
enzym
jackman
et
al
prolylcarboxypeptidas
hand
cleav
nativ
bk
lack
penultim
pro
residu
ligand
b
receptor
ctermin
proph
sequenc
readili
cleav
enzym
yang
et
al
yang
et
al
odya
et
al
fig
thu
carboxypeptidas
potenti
may
import
regul
receptor
signal
system
metallocarboxypeptidas
carboxypeptidas
n
deamidas
gener
desarg
fig
bind
b
receptor
upregul
inflamm
see
chapter
prolylcarboxypeptidas
releas
inflammatori
cell
would
cleav
ctermin
phe
inactiv
fig
previou
studi
report
prolylcarboxypeptidas
releas
blood
endotoxin
shock
potent
stimulu
upregul
b
receptor
see
aminopeptidas
catalyz
remov
one
amino
acid
time
nterminu
peptid
protein
although
ntermin
sequenc
bk
contain
pro
second
posit
render
nonapeptid
resist
aminopeptidas
aminopeptidas
p
specif
cleav
peptid
pro
second
posit
therefor
capabl
inactiv
bk
fig
aminopeptidas
also
particip
releas
bk
exampl
lysbk
kallidin
liber
tissu
kallikrein
wherea
bk
product
plasma
kallikrein
bhoola
et
al
lysbk
convert
bk
aminopeptidas
action
blood
similar
activ
detect
varieti
tissu
erdr
howev
mention
elsewher
chapter
necessari
lysbk
convert
bk
inactiv
peptidas
inactiv
directli
enzym
ace
carboxypeptidas
n
erdr
dipeptidyl
aminopeptidas
iv
specif
catalyz
remov
dipeptid
ntermini
peptid
pro
second
posit
mcdonald
barrett
cleav
bk
hydrolyz
propro
bond
nevertheless
secondari
metabol
step
would
releas
propro
desargbk
propro
detect
one
metabolit
bk
pass
lung
ryan
et
al
long
known
aminopeptidas
p
contribut
bk
metabol
vitro
erdr
et
al
erdr
yang
perfus
rat
lung
situ
ryan
et
al
enzym
partial
purifi
character
pig
kidney
dehm
nordwig
purifi
homogen
properti
describ
detail
recent
hooper
et
al
simmon
orawski
orawski
simmon
verga
romero
et
al
arninopeptidas
p
membran
bound
via
gpi
anchor
solubil
piplc
hooper
turner
hooper
et
al
simmon
orawski
orawski
simmon
denatur
condit
sdspage
aminopeptidas
p
run
singlechain
protein
r
glycoprotein
contain
carbohydr
weight
hooper
et
al
simmon
orawski
orawski
simmon
gelfiltr
chromatographi
purifi
enzym
multimer
structur
molecular
mass
kda
hooper
et
al
simmon
orawski
orawski
simmon
vari
depend
salt
concentr
partial
protein
sequenc
aminopeptidas
p
purifi
guineapig
lung
kidney
denslow
et
al
flail
sequenc
pig
kidney
enzym
verga
romero
et
al
show
aminopeptidas
p
sequenc
similar
human
e
coli
prolidas
well
e
coli
aminopeptidas
p
thu
enzym
may
constitut
newli
recogn
famili
prolin
peptidas
earli
studi
indic
presenc
solubl
cytosol
form
aminopeptidas
p
kidney
extract
dehm
nordwig
form
enzym
purifi
character
sourc
includ
human
lung
human
erythrocyt
rat
brain
human
platelet
sidorowicz
et
al
b
harbeck
mentlein
vanhoof
et
al
solubl
enzym
differ
membranebound
form
structur
substrat
specif
see
exampl
solubl
aminopeptidas
p
purifi
rat
brain
r
sdspage
nativ
r
gel
filtrat
harbeck
menflein
membranebound
aminopeptidas
p
cleav
peptid
bk
neuropeptid
npi
contain
pro
second
posit
ph
optimum
neutral
rang
simmon
orawski
tripeptid
glyprohyp
commonli
use
substrat
measur
activ
although
ntermin
tripeptid
ofbk
argpropro
cleav
much
faster
simmon
orawski
orawski
simmon
aminopeptidas
p
also
cleav
longer
substrat
dipeptid
argpro
simmon
orawski
orawski
simmon
aminopeptidas
p
zinc
metallopeptidas
contain
one
zinc
per
mole
enzym
hooper
et
al
enzym
activ
presenc
mn
substrat
inhibit
chelat
agent
inhibitor
includ
sdflaydryl
compound
well
sulflaydrylreact
reagent
eg
pchloromercuriphenylsulfon
hooper
et
al
simmon
orawski
orawski
simmon
interestingli
mani
ace
inhibitor
also
inhibit
aminopeptidas
p
although
gener
micromolar
rang
hooper
et
al
mn
enhanc
inhibitori
effect
inhibit
like
due
presenc
pro
prolik
structur
ace
inhibitor
effect
zinc
bind
moieti
would
chelat
activ
site
metal
aminopeptidas
p
ace
whether
effect
side
effect
ace
inhibitor
could
due
inhibit
aminopeptidas
p
known
enzymat
properti
solubl
form
aminopeptidas
p
similar
membranebound
form
regard
ph
optimum
inhibitor
activ
mn
sidorowicz
et
al
b
harbeck
mentlein
vanhoof
et
al
unlik
membranebound
enzym
howev
solubl
form
readili
cleav
dipeptid
sidorowicz
et
al
b
harbeck
mentlein
simmon
orawski
vanhoof
et
al
orawski
simmon
may
indic
solubl
form
differ
gene
product
simpli
solubil
membranebound
aminopeptidas
p
aminopeptidas
ptype
activ
detect
varieti
tissu
base
purif
studi
clear
lung
kidney
contain
high
concentr
membranebound
aminopeptidas
p
wherea
solubl
cytosol
enzym
also
present
brain
erythrocyt
platelet
dehm
nordwig
sidorowicz
et
al
b
hooper
et
al
harbeck
mentlein
simmon
orawski
vanhoof
et
al
orawski
simmon
lung
membranebound
form
like
local
surfac
pulmonari
vascular
endotheli
cell
access
circul
peptid
bk
ryan
first
studi
b
k
metabol
discov
one
mechan
inactiv
consist
remov
ntermin
arg
residu
et
al
type
activ
human
erythrocyt
et
al
porcin
kidney
yang
initi
attribut
prolidas
recogn
prolidas
cleav
xpro
dipeptid
aminopeptidas
p
major
enzym
respons
remov
ntermin
arg
bk
fig
overal
role
aminopeptidas
p
degrad
b
k
vivo
investig
detail
recent
earli
studi
perfus
rat
lung
show
one
pathway
bk
degrad
involv
remov
ntermin
arg
residu
ryan
et
al
two
recent
studi
also
perfus
rat
lung
care
assess
rel
contribut
ace
amhaopeptidas
p
bk
metabol
case
conclud
ace
major
kininas
rat
lung
respons
total
metabol
essenti
bk
hydrolysi
could
account
combin
action
ace
aminopeptidas
p
prechel
et
al
nevertheless
even
ace
activ
block
complet
bk
still
inactiv
singl
passag
aminopeptidas
p
alon
prechel
et
al
studi
vivo
corrobor
data
administr
specif
aminopeptidas
p
inhibitor
apstatin
doubl
hypotens
action
bk
rat
scicli
et
al
person
commun
furthermor
apstatin
much
less
effect
lisinopril
specif
ace
inhibitor
confirm
primari
role
ace
kinin
metabol
rat
lung
relev
find
somewhat
question
rat
lung
contain
extrem
high
level
aminopeptidas
p
rel
speci
ryan
exampl
aminopeptidas
p
level
rat
lung
higher
rabbit
lung
higher
pig
lung
higher
cat
lung
ryan
aminopeptidas
p
could
also
play
role
degrad
desarggbk
fig
vitro
kinet
essenti
ident
bk
simmon
orawski
orawski
simmon
hand
specif
constant
desarggbk
ace
much
less
favor
bk
owe
much
higher
k
ixm
vs
im
bk
inokuchi
nagamatsu
oshima
et
al
thu
ace
would
probabl
play
much
less
promin
role
degrad
desarggbk
vivo
wherea
rel
import
aminopeptidas
p
would
like
increas
howev
pathway
degrad
vivo
yet
well
character
endopeptidas
enzym
cleav
peptid
interior
peptid
chain
specif
depend
mainli
amino
acid
one
side
peptid
bond
cleav
endopeptidas
enzym
role
kininas
discuss
section
present
review
sever
endopeptidas
cleav
bk
least
vitro
fig
role
kininas
vivo
fitli
understood
consid
briefli
meprin
origin
purifi
mous
kidney
membran
fraction
mous
homolog
human
benzoylltyrosylpaminobenzo
acid
paba
peptid
hydrolas
rat
endopeptidas
beynon
et
al
butler
et
al
dumermuth
et
al
wolz
bond
purif
sequenc
studi
reveal
meprin
consist
two
uniqu
relat
subtmit
show
meprin
member
astacin
famili
ofmetauoproteas
dumermuth
et
al
gorbea
etal
jiang
etal
johnson
hersh
wolz
bond
enzym
oligomer
cellsurfac
protein
bound
via
transmembran
subunit
subunit
either
disulfidelink
noncoval
bound
johnson
hersh
marchand
et
al
meprin
detect
kidney
intestin
express
vari
speci
speci
even
within
differ
strain
speci
jiang
et
al
jiang
et
al
contrast
endopeptidas
endopeptidas
ace
hydrolyz
short
peptid
meprin
cleav
larg
protein
substrat
azocasein
buffer
et
al
subunit
meprin
hydrolyz
peptid
protein
substrat
longer
seven
amino
acid
cleav
glyph
bond
bk
buffer
et
al
fig
ofau
peptid
test
b
k
hydrolyz
fastest
among
cleav
singl
site
wolz
etal
tabl
find
led
synthesi
phe
bk
develop
first
conveni
spectrophotometr
assay
meprin
bond
subunit
primarili
latent
form
cleav
bk
activ
kounna
etal
wolz
bond
meprina
broad
substrat
specif
strict
requir
residu
adjac
cleavag
site
seem
prefer
pro
posit
meprina
also
cleav
amelanocytestimul
hormon
neurotensin
lhrh
also
hydrolyz
angiotensin
ii
rather
slowli
unlik
meprin
play
domin
role
degrad
kinin
prolylendopeptidas
cytoplasm
enzym
found
tissu
especi
high
concentr
brain
kidney
wilk
serin
proteas
molecular
mass
kda
optim
activ
ph
wilk
clone
sequenc
porcin
brain
enzym
reveal
differ
classic
serin
proteas
sequenc
around
activ
site
serin
rennex
et
al
comparison
known
enzym
identifi
member
new
famili
serin
proteas
rawl
et
al
enzym
catalyt
triad
similar
serin
proteas
uniqu
order
ser
asp
primari
sequenc
polgar
prolylendopeptidas
cleav
ctermin
side
prolyl
residu
peptid
less
amino
acid
wilk
hydrolyz
bk
cleavag
pro
bond
fig
site
ace
nep
wilk
purifi
porcin
kidney
enzym
bk
k
vm
mol
min
mg
ward
et
al
tabl
prolylendopeptidas
also
cleav
desarggbk
releas
ctermin
phe
fig
kinet
similar
bk
ward
et
al
consequ
enzym
inactiv
ligand
b
b
kinin
receptor
prolylendopeptidas
cleav
varieti
peptid
contain
pro
wilk
role
prolylendopeptidas
well
understood
local
cytosol
would
normal
access
peptid
hormon
synthes
secret
extraceuularli
even
present
signific
concentr
blood
import
bk
metabol
would
minor
experi
util
potent
prolylendopeptidas
inhibitor
cbzproprolin
may
help
elucid
role
peptid
metabol
wilk
orlowski
interpret
result
inhibitor
may
complic
fact
also
rel
potent
inhibitor
activ
prolylcarboxypeptidas
tan
et
al
cleav
substrat
endopeptidas
origin
purifi
solubl
fraction
rat
brain
homogen
enzym
extract
cleav
varieti
biolog
activ
peptid
subsequ
studi
led
realiz
enzym
ident
two
enzym
describ
purifi
earlier
pzpeptidas
cleav
synthet
couagenas
substrat
endooligopeptidas
first
describ
kininas
review
see
tisljar
barrett
et
al
endopeptidas
ph
optimum
neutral
rang
metauoenzym
reveal
biochem
studi
well
primari
sequenc
contain
consensu
hexxh
motif
zinc
metalloenzym
orlowski
et
al
pierotti
et
al
tisljar
enzym
also
sensit
inhibit
sulflaydrylreact
agent
stabl
activ
presenc
low
concentr
thiolcontain
compound
orlowski
et
al
tisljar
barrett
led
one
group
classifi
cystein
peptidas
anoth
propos
renam
thimet
oligopeptidas
describ
dual
natur
tisljar
barrett
et
al
howev
enzym
clearli
metallopeptidas
sensit
thiol
like
result
presenc
free
cystein
remov
five
residu
catalyt
center
residu
probabl
involv
catalyt
mechan
pierotfi
et
al
endopeptidas
singlechain
enzym
amino
acid
molecular
mass
kda
pierotti
et
al
tisljar
although
contain
singl
potenti
glycosyl
site
evid
enzym
glycosyl
pierotti
et
al
endopeptidas
primarili
cytosol
enzym
observ
consist
lack
signal
peptid
pierotti
et
al
although
enzym
may
membraneassoci
acker
et
al
endopeptidas
attach
membran
clear
primari
sequenc
obviou
transmembran
domain
pierotti
et
al
enzym
ubiquit
distribut
especi
highli
concentr
brain
test
tisljar
barrett
et
al
endopeptidas
rather
broad
substrat
specif
activ
cleav
carboxyl
side
hydrophob
aromat
amino
acid
especi
contain
aromat
residu
p
posit
explain
readili
cleav
bk
phesser
bond
aromat
phe
residu
p
posit
fig
tabl
endopeptidas
hydrolyz
biolog
activ
peptid
includ
neurotensin
substanc
p
lhrh
convert
larg
opioid
peptid
enkephalin
chu
orlowski
ace
endopeptidas
endopeptidas
hydrolyz
peptid
shorter
residu
chu
orlowski
tisljar
cytosol
local
endopeptidas
make
physiolog
relev
kininas
question
although
small
portion
around
membran
bound
subcellular
fraction
rat
brain
acker
et
al
clear
whether
repres
enzym
present
exterior
surfac
plasma
membran
bound
intracellular
membran
nevertheless
studi
use
endopeptidas
inhibitor
n
l
rs
alaalaphepab
cfpaafpab
orlowski
et
al
suggest
possibl
involv
enzym
inactiv
b
k
vivo
situ
exampl
cfpaafpab
enhanc
b
kinduc
contract
rat
uteru
schriefer
molineaux
block
bk
degrad
rat
hypothalam
slice
mcdermott
et
al
intraven
infus
cfpaafpab
normotens
rat
result
immedi
drop
blood
pressur
mm
hg
block
b
receptor
antagonist
genden
molineaux
inhibitor
also
increas
potenc
iv
infus
bk
tenfold
howev
data
recent
shown
due
primarili
indirect
inhibit
ace
cfpaafpab
hydrolysi
inhibitor
endopeptidas
cardozo
orlowski
effect
anim
pretreat
ace
inhibitor
yang
et
al
telford
et
al
endopeptidas
neurotensindegrad
enzym
neurolysin
first
describ
enzym
degrad
neurotensin
rat
brain
membran
checler
et
al
properti
similar
endopeptidas
clear
repres
new
enzym
howev
subsequ
purif
character
enzym
prove
uniqu
checler
et
al
checler
et
al
millican
et
al
recent
studi
reveal
enzym
like
ident
solubl
angiotensin
iibind
protein
rabbit
microsom
endopeptidas
least
partli
local
mitochondri
intermembran
space
serizawa
et
al
sequenc
identifi
member
famili
endopeptidas
purifi
endopeptidas
cleav
bk
site
endopeptidas
fig
millican
et
al
cytosol
mitochondri
local
endopeptidas
appear
preclud
metabol
b
k
normal
circumst
clear
decad
research
ace
vascular
endotheli
cell
surfac
import
inactiv
bloodborn
bk
howev
also
becom
evid
bk
may
act
primarili
autocrin
paracrin
fashion
carretero
scicli
establish
import
local
regul
activ
enzym
cell
surfac
skidgel
thu
assort
enzym
inactiv
bk
may
import
varieti
physiolog
patholog
situat
addit
physiolog
system
redund
pathway
metabol
abolish
one
pathway
compens
presenc
other
vividli
demonstr
pharmacolog
inhibit
ace
hypertens
although
side
effect
might
attribut
potenti
respons
bk
eg
cough
angioedema
drug
surprisingli
well
toler
demonstr
effect
peptidas
minim
potenti
deleteri
effect
excess
kinin
cleavag
bk
peptidas
specif
site
lead
futur
develop
peptidas
inhibitor
may
use
condit
potenti
action
b
k
elev
concentr
desir
featur
studi
carboxypeptidas
n
describ
support
part
nih
grant
thank
sara
thorburn
help
prepar
manuscript
